BOSTON, MA – Diversified Healthcare Trust has sold an additional 10% equity interest in a life science complex in Boston's Seaport district to an existing joint-venture partner for $108 million.
The class A, two-building complex features 1.1 million rentable square feet of lab, office and street-level retail space. Located at 11 Fan Pier and 50 Northern Ave., the two 15-story properties are LEED Gold certified and are 95% leased to Vertex Pharmaceuticals Inc.
The purchase partner now owns a 45% interest in the joint-venture. DHC owns 10% equity interest and another partner owns the remaining 45% equity interest.
Recommended For You
The purchase price for the 10% equity interest is based on a $1.7 billion property valuation, less the $620 million of existing secured debt on the property.
DHC plans to use the transaction's proceeds to fund capital expenditures, reduce outstanding indebtedness and for other general business purposes.
DHC originally acquired the life science complex in May 2014 for $1.1 billion. The REIT now owns more than 100 life science and medical office properties, totaling nine million square feet.
DHC and the joint-venture are managed by the RMR Group.
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Ingrid Tunberg
Ingrid Tunberg sits on the editorial team as a coordinator and reporter for Real Estate Forum and GlobeSt.com. She is responsible for writing stories, assisting with industry awards and marketing nomination events. Previously, Ingrid worked as a copywriter across various industries throughout New York City and Chicago.
